Genetics of Drug Metabolism Clinical Trial
Official title:
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
UPGRADE aims to see whether data from Pharmacogenomic Testing (PGx) can help physicians
manage patient medication regimens and assess if the testing has an effect on reducing
adverse drug reactions, hospitalizations and emergency department visits.
The way an individual processes a drug is in part determined by their genes, and there is
known to be genetic variation between humans in the way drugs are metabolized. The study of
the way genes affect a person's response to drugs is known as "Pharmacogenomics."
n/a
Observational Model: Cohort
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT01970709 -
Diagnosing Adverse Drug Reactions Registry
|
N/A | |
| Recruiting |
NCT02095769 -
Pharmacogenomic Testing Of the Elderly To Reduce Morbidity
|
N/A |